Dr J. Penders

Barnett, D., Thijs, C., Mommers, M., Endika, M., Klostermann, C., Schols, H., Smidt, H., Nauta, A., Arts, I., & Penders, J. (2025). Why do babies cry? Exploring the role of the gut microbiota in infantile colic, constipation, and cramps in the KOALA birth cohort study. Gut Microbes, 17(1), Article 2485326. https://doi.org/10.1080/19490976.2025.2485326

Maasjosthusmann, P., Wenglein, J. S., Hamelmann, E., & Penders, J. (2025). Frühkindliches Mikrobiom: Diversität und Funktion als wichtiger Schlüssel für Gesundheit und Krankheit. Monatsschrift Kinderheilkunde, 173(8), 646-653. https://doi.org/10.1007/s00112-025-02215-8

Bohm, D., Russ, E., Guchelaar, H.-J., Ziemons, J., Penders, J., Smidt, M. L., van Best, N., & Deenen, M. J. (2025). The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review. npj Precision Oncology, 9(1), Article 265. https://doi.org/10.1038/s41698-025-01034-0

Russ, E., Ziemons, J., Hillege, L. E., van Kuijk, S. M. J., de Jong, E. M., Elbers, C., Deenen, M. J., Borghuis, L. H., Bohm, T. M. M., Kristen, P., Valk, L. C., van Hellemond, I. E. G., Vestjens, H., Dietvorst, A., Baars, A., Goosens, A. N. M., Vermeulen, L., Buffart, T. E., de Vos-Geelen, J., ... Smidt, M. L. (2025). Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer-study protocol of the OPTIMA study. BMC Cancer, 25(1), Article 1129. https://doi.org/10.1186/s12885-025-14500-6

Pyuza, J. J., van Dorst, M. M. A. R., Barnett, D., Stam, K., Manurung, M., Wammes, L., Konig, M., Kruize, Y., Andongolile, N., Ngowi, A., Shao, E. R., Kullaya, V. I., Mremi, A., Hogendoorn, P. C. W., Msuya, S. E., Jochems, S. P., Penders, J., Yazdanbakhsh, M., & Piters, W. A. A. D. S. (2025). Tanzanian gut microbiota profiles linked to high but rapidly waning yellow fever antibody titers. npj Biofilms Microbomes, 11(1), Article 110. https://doi.org/10.1038/s41522-025-00687-w

Schoultz, I., Claesson, M. J., Dominguez-Bello, M. G., Fåk Hållenius, F., Konturek, P., Korpela, K., Laursen, M. F., Penders, J., Roager, H., Vatanen, T., Öhman, L., & Jenmalm, M. C. (2025). Gut microbiota development across the lifespan: Disease links and health-promoting interventions. Journal of Internal Medicine, 297(6), 560-583. Article 20089. https://doi.org/10.1111/joim.20089

Hillege, L. E., Trepka, K. R., Guthrie, B. G. H., Fu, X., Aarnoutse, R., Paymar, M. R., Olson, C., Zhang, C., Ortega, E., Ramirez, L., de Vos-Geelen, J., Valkenburg-van Iersel, L., van Hellemond, I. E. G., Baars, A., Vestjens, J. H. M. J., Penders, J., Deutschbauer, A., Atreya, C. E., Kidder, W. A., ... Turnbaugh, P. J. (2025). Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicity. Mbio, 16(6). https://doi.org/10.1128/mbio.00930-25

van Duuren, I. C., Smits, H. H., Duijts, L., Penders, J., & Tramper-Stranders, G. A. (2025). PROTEA study: a protocol for a randomised controlled trial evaluating the efficacy, immune effects and cost-effectiveness of oral bacterial lysate therapy to protect moderate-late preterm infants from respiratory tract infections and wheezing. ERJ Open Research, 11(3), Article 00591-2024. https://doi.org/10.1183/23120541.00591-2024

Kelderer, F., Granåsen, G., Holmlund, S., Silfverdal, S. A., Bamberg, H., Mommers, M., Penders, J., Domellöf, M., Mogren, I., & West, C. E. (2025). Respiratory Morbidity Before and During the COVID-19 Pandemic from Birth to 18 Months in a Swedish Birth Cohort. Journal of Allergy and Clinical Immunology, 155(4), 1214-1223.e10. https://doi.org/10.1016/j.jaci.2024.12.1080

Endika, M. F., Barnett, D. J. M., Olmos, E. M., Ter Braak, C. J. F., Arts, I. C. W., Penders, J., Nauta, A., Leemhuis, H., Venema, K., & Smidt, H. (2025). Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant. FEMS microbiology ecology, 101(4), Article fiaf028. https://doi.org/10.1093/femsec/fiaf028